Quinoline radionuclide probe based on FAP has been designed for imaging and targeted therapy, which can make up for the limitation of insufficient expression of PSMA in PCa, but its application scope may be limited to well-differentiated PCa. The gene discussed is FAP; the disease is posterior cortical atrophy.